Oxymatrine combined with cisplatin enhances expression of vascular endothelial growth factor and CD31 in subcutaneous xenografts of human hepatocellular carcinoma in nude mice
Basic Medicine|更新时间:2026-01-09
|
Oxymatrine combined with cisplatin enhances expression of vascular endothelial growth factor and CD31 in subcutaneous xenografts of human hepatocellular carcinoma in nude mice
Journal of Third Military Medical UniversityVol. 40, Issue 2, Pages: 136-140(2018)
Jing HU, Zansong HUANG, Gaoyu HU, et al. Oxymatrine combined with cisplatin enhances expression of vascular endothelial growth factor and CD31 in subcutaneous xenografts of human hepatocellular carcinoma in nude mice[J]. Journal of Third Military Medical University, 2018, 40(2): 136-140.
DOI:
Jing HU, Zansong HUANG, Gaoyu HU, et al. Oxymatrine combined with cisplatin enhances expression of vascular endothelial growth factor and CD31 in subcutaneous xenografts of human hepatocellular carcinoma in nude mice[J]. Journal of Third Military Medical University, 2018, 40(2): 136-140. DOI: 10.16016/j.1000-5404.201708092.
Oxymatrine combined with cisplatin enhances expression of vascular endothelial growth factor and CD31 in subcutaneous xenografts of human hepatocellular carcinoma in nude mice
To study the effect of oxymatrine combined with cisplatin on the expression of vascular endothelial growth factor (VEGF) and platelet-endothelial cell adhesion molecule CD31 in human hepatocellular carcinoma xenografts in nude mice.
Methods
2
Nude mice bearing human hepatocellular carcinoma xenografts were randomly divided into 4 groups for intraperitoneal injections with normal saline (control)
cisplatin
oxymatrine
or both oxymatrine and cisplatin. Fifteen days after the injections
the mice were sacrificed for examination of the expression of VEGF and CD31 in the subcutaneous xenografts with immunohistochemical staining.
Results
2
In the tumor-bearing mice treated with both oxymatrine and cisplatin
the tumor volume was significantly smaller than that in the other 3 groups (
P
<
0.05)
and the positive rate for VEGF in the subcutaneous xenograft was 20%
significantly lower than the rate of 80% in oxymatrine group
70% in the cisplatin group and 100% in the control group (
P
<
0.05). The positive rate of CD31 in the xenograft was 30% in the combined treatment group
also significantly lower than the rates in matrine group (90%)
cisplatin group (70%) and control group (100%) (
P
<
0.05).
Conclusion
2
Oxymatrine combined with cisplatin can inhibit the expression of VEGF and CD31 in subcutaneous xenografts of human hepatocellular carcinoma and delay tumor growth in nude mice.
ZHANG Z L, MAO X W, ZHANG J F, et al .Effects of angiopoietin 2 single-chain antibody on human hepatocellular carcinoma in nude mice[J ] .Chin J Exp Surg, 2013, 30(8): 1642-1645.DOI: 10.3760/cma.j.issn.1001-9030.2013.08.028.
ZHOU J M, XIANG H L, ZHU Z Y, et al .Differentiation of bone marrow mesenchymal stem cells into endothelial cells induced by rat CBRH-7919 hepatoma cells in vitro [J ] .Chin J Mod Med, 2012, 22(29): 21-25..
Cristina C, Perez-Millan MI, Luque G, et al .VEGF and CD31 association in pituitary adenomas[J ] .Endocr Pathol, 2010, 21(3): 154-160.DOI:10.1007/s12022-010-9119-6.
XU H P, GUO R, JIN Y Y, et al .Gene-targeted radiation therapy mediated by radiation-sensitive promoter in lung adenocarcinoma and the feasibility of micro-PET/CT in evaluation of therapeutic effectiveness in small animals[J ] .Chin J Oncol, 2014, 36(5): 329-334.DOI: 10.3760/cma.j.issn.0253-3766.2014.05.003.
LIU C Y, DONG H, CHENG H, et al .Correlation between VEGF-C, nm23-H1 and CD31 in papillary thyroid carcinoma[J ] .Chin J Diagn Pathol, 2017, 24(4): 284-287.DOI: 10.3969/j.issn.1007-8096.2017.04.013.
LI M Y, HE W K, CHEN J W, et al .Effects of Ad-HIF-1α-Trip transfer on angiogenesis and blood perfusion in a rat model of hind limb ischemia[J ] . J Third Mil Med Univ, 2012, 34(15): 1518-1522.
Kasprzak A, Surdacka A, Tomczak M, et al .Expression of angiogenesis-stimulating factors (VEGF, CD31, CD105) and angiogenetic index in gingivae of patients with chronic periodontitis[J ] .Folia Histochem Cytobiol, 2012, 50(4): 554-564.DOI:10.5603/20324.
FU H D, LUO Q S, DENG Y Y, et al .Expression of Hepatoma-derived Growth Factor and Vascular Endothelial Growth Factor and Their Correlation With Tumor Microvessel Density in Gliomas[J ] .Chin Gen Pract, 2016, 19(17): 2019-2023.DOI:10.3969/j.issn.1007-9572.2016.17.008.
SI C F, LU M Y, WANG Q Y, et al .Improved antitumor efficacy by combinationtreatment with recombined VEGF protein vaccineand cyclophosphamide in H22 hepatocellular carcinoma bearing-mice[J ] .Chin Pharmacul Bull, 2017, 33(5): 617-621.DOI: 10.3969/j.issn.1001-1978.2017.05.006.
GENG L, FAN J, GAO Q L, et al .Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice[J ] . J Peking Univy(Health Sci), 2016, 48(3): 496-501.DOI: 10.3969/j.issn.1671-167X.2016.03.021.
HU Z, WANG P E, QU H J.The dynamic changes of serum VEGF, CTGF, HIF-1 and OPN levels in patients with advanced liver cancer treated with Sola Feeney combined with TACE[J].Chin J Biochem Pharm, 2017, 38(4): 345-347, 350.DOI: 10.3969/j.issn.1005-1678.2017.04.114.
WANG Q C, WANG Q, WAN L X, et al .The study of expression of Tiam1, VEGF and CD31 in esophageal squamous cell carcinoma and their correlations of them[J ] .Chin Med Herald, 2012, 9(23): 95-96.DOI: 10.3969/j.issn.1673-7210.2012.23.040.
WANG G, CHENG X, ZHANG X L, et al .Effect of shRNA-CXCR7 combined with TRAIL on subcutaneous transplantation tumor of SMMC-7721 cell line in nude mice[J ] .Chin J Biochem Pharm, 2016, 37(1): 28-31.
GAO J, ZHU X Y, SHI Q F, et al .Mechanism and inhibition of thalidomide combined with epirubicine on the growth of transplanted H22 hepatocellular carcinoma in mice[J ] .Chin J Clin Pharmacol, 2016, 32(2): 170-173.DOI: 10.13699/j.cnki.1001-6821.2016.02.024.
FANG L, ZHAO Z, WU Q N, et al .Influence and significance of hepatic transcatheter arterial chemoembolization combime with endostar on l evels of serum VEGF, HIF-1A, OPN and MMP-9 in patients with hepatocellular carcinoma[J ] .Chin J Gen Pract, 2016, 14(3): 412-414.DOI: 10.16766/j.cnki.issn.1674-4152.2016.03.025.